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The ventral pancreas, biliary system, and liver arise
from the posterior ventral foregut, but the cell-
intrinsic pathway by which these organ lineages are
separated is not known. Here we show that the extra-
hepatobiliary systemsharesacommonoriginwith the
ventral pancreas and not the liver, as previously
thought. These pancreatobiliary progenitor cells co-
express the transcription factors PDX1 and SOX17
at E8.5 and their segregation into a PDX1+ ventral
pancreas and a SOX17+ biliary primordium is Sox17-
dependent. Deletion of Sox17 at E8.5 results in the
lossofbiliarystructuresandectopicpancreatic tissue
in the liver bud and common duct, while Sox17 over-
expression suppresses pancreas development and
promotes ectopic biliary-like tissue throughout the
PDX1+domain.RestrictingSOX17+biliaryprogenitor
cells to the ventral region of the gut requires the notch
effector Hes1. Our results highlight the role of Sox17
and Hes1 in patterning and morphogenetic segrega-
tion of ventral foregut lineages.
INTRODUCTION
The ventral foregut endoderm of the mammalian embryo is
a simple epithelium of several hundred cells, yet it gives rise to
a spectrum of organs and structures including the lungs, thyroid,
liver, hepatobiliary system (intrahepatic bile ducts [IHBD], extra-
hepatic bile ducts [EHBD], common duct, gall bladder, and
cystic duct), and ventral portions of the pancreas, stomach,
and duodenum. Studies indicate that the most anterior part of
the ventral foregut gives rise to thyroid and lung, whereas the
posterior region give rise to the liver, biliary system, and the
ventral pancreas (Fukuda and Mizuno, 1978; Le Douarin, 1968,
1988; Rosenquist, 1971; Tremblay and Zaret, 2005). Several
studies have demonstrated how signaling cascades and tran-
scription factors influence foregut organ specification (see
below). However, the exact lineage relationship between the
liver, extraheptobiliary system, and the ventral pancreas is not
clear nor have the cell intrinsic factors been identified that62 Developmental Cell 17, 62–74, July 21, 2009 ª2009 Elsevier Inc.mediate separation of these lineages from a common group of
foregut progenitor cells.
Studies using embryonic explants, lineage tracing, gene
expression analyses, and mouse genetics indicate that several
different signaling pathways and transcription factors are
involved in the specification and development of foregut organs.
Foregut explant cultures and genetics have identified that meso-
derm-derived signals, including FGF and BMP ligands, act to
pattern the ventral foregut into liver, pancreas, and lung (Deutsch
et al., 2001; Dong et al., 2007; Gualdi et al., 1996; Jacquemin
et al., 2006; Serls et al., 2005; Shin et al., 2007), and in the sepa-
ration of the liver and pancreatic lineages (Chung et al., 2008).
Other pathways implicated in development of hepatic, pancre-
atic, and biliary systems include the FGF10 and Hedgehog
signaling pathways (Bhushan et al., 2001; Dong et al., 2007;
Manfroid et al., 2007; Hebrok et al., 2000; Kim and Melton,
1998; Litingtung et al., 1998). A large body of work has detailed
many transcription factors that are required for specification of
individual organs, including the liver (Foxa2, Foxa1, and Hhex)
and pancreas (Ptf1a/p48, Pdx1, and Hhex) (Bort et al., 2004,
2006; Kawaguchi et al., 2002; Krapp et al., 1998; Lee et al.,
2005a; Offield et al., 1996). Despite these significant advances,
the cell-intrinsic mechanisms by which this common pool of
foregut progenitor cells gives rise to distinct organ lineages,
and how organ boundaries are subsequently established and
maintained is less clear.
The biliary system is derived from the same region of the
ventral foregut as the liver and pancreas, yet relatively little is
known about early biliary development. Based on histological
evidence, it has been suggested that the hepatic diverticulum
gives rise to the liver, as well as the IHBD, EHBD, cystic duct,
and gall bladder primordium. Knockout experiments in the
mouse have identified several transcription factors, Hhex,
HNF6, and HNF1b, that are required for biliary development
(Clotman et al., 2002; Coffinier et al., 2002; Hunter et al., 2007).
Several of these also affect liver development, again suggesting
the liver and biliary system share a common origin. The ventral
pancreas also arises from the same region of the ventral foregut
as the hepatic and biliary system and loss of the Notch effector
Hes1 results in gall bladder agenesis and ectopic pancreatic
tissue in the common duct. This finding suggests a develop-
mental link between the biliary system and the pancreas (Burke
et al., 2004; Fukuda et al., 2006; Sumazaki et al., 2004). This
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humans in which linked anomalies affect both the pancreas and
biliary system (Ashraf et al., 2005; Chappell et al., 2008; Galan-
Gomez et al., 2007; Heij and Niessen, 1987; Iguchi et al., 2005;
Martinoli et al., 1980; Mehes et al., 1976; Mitchell et al., 2004).
Despite all of this correlative evidence, the lineage relationship
between the biliary system and either the liver or the pancreas
has not been experimentally demonstrated.
Sox17 is necessary for definitive endoderm formation in many
vertebrate species including Xenopus, zebrafish, and mouse.
However, early embryonic lethality in Sox17 null mice has made
studying its role during organogenesis impossible (Kanai-Azuma
et al., 2002). In Xenopus, SOX17 interacts with cofactors to acti-
vate transcription of target genes, such as Hnf1b, that are known
to be required for later development of endodermal organs
(Sinner et al., 2004, 2006; Zorn et al., 1999). Moreover, our data
indicate thatSox17expression is maintained in the posterior fore-
gut, suggesting to us that Sox17 might have a function during
ventral foregut organogenesis.
We used a combination of gene expression analysis, lineage
tracing, and mouse genetics to investigate the lineage relation-
ship between the biliary system, pancreas, and liver, and to iden-
tify cell-intrinsic pathways that separate these organ lineages
from a common progenitor. We identified: (1) The biliary system
and ventral pancreas arise from a common progenitor that is
distinct from the liver at E8.5; (2) Sox17 is a key regulator in the
early segregation these organ lineages; (3) Loss of Sox17 results
in PDX1-expressing cells in the liver bud and ectopic pancreatic
tissue in the common duct; (4) Sox17 is necessary and sufficient
for specifying a ductal fate; and (5) Hes1 is required for sepa-
rating the biliary and pancreatic lineages and may act in a feed-
back loop with Sox17.
Together with published findings, our data support a model
where SOX17 is broadly expressed in foregut progenitor cells
and is progressively downregulated in cells as they become
lineage restricted. For example, downregulation of SOX17 in
PDX1-expressing cells is required for pancreas development.
This model illustrates how one transcription factor, SOX17,
might act in combination with others factors like HHEX and
PDX1 to specify different organ lineages from a common pool
of progenitor cells.
RESULTS
PDX1 and SOX17 Coexpression Defines a Common
Ventral Foregut Progenitor
Sox17 is required for endoderm formation, but its role in later
endoderm development is not known. We evaluated the expres-
sion pattern ofSox17mRNA and protein at E8.5 and found both in
ventral foregut domain that largely overlaps with PDX1 (Figure 1A;
see Figure S1A available online). This SOX17+/PDX1+ domain is
caudal to the thickening pseudostratified epithelium of the
hepatic diverticulum, which is HHEX positive at this stage
(Figure 1A). Very few cells at the boundary of the two domains
were HHEX+/SOX17+/PDX1+ (Figure 1A). Over the next 24 hr
of development (E9.5), the SOX17 and PDX1 coexpression
domain progressively separates into a SOX17+ biliary primor-
dium (also called primordial gall bladder) and a PDX1+ pancreatic
primordia (Figure 1, Figure S1). Analysis ofSox17mRNA by in situhybridization completely coincided with SOX17 protein expres-
sion (Figures S1B and S1C). These expression patterns indicate
a role for Sox17 development of the biliary system and pancreas.
The Biliary Primordium, Extrahepatobiliary System,
and Ventral Pancreas Develop from PDX1+ Cells
Our expression data led us to hypothesize that the biliary system is
not derived from the liver primordium as previouslysuggested,but
rather shares a common origin with the ventral pancreas and
comes from the PDX1+/SOX17+ progenitor cells in the ventral
foregut. To determine if the biliary system is derived from
a PDX1+ progenitor, we performed a lineage tracing experiment
with a Pdx1-Cre transgenic line (Wells et al., 2007) and a Rosa
reporter mouse. PDX1-expressing cells were lineage-labeled
starting at E8.5, and analysis at E9.5 and E10.5 embryos demon-
strated that the biliary primordium was LacZ-positive and thus
was derived from PDX1-expressing progenitor cells (Figures 1C
and 1E). Since the E10.5 biliary primordium is negative for PDX1
protein, these cells must be a descendent of an earlier Pdx1-cre
expressing cell. Analysis of E16.5 embryos indicated that the
epithelia of the duodenum, dorsal and ventral pancreas, and the
extrahepatobiliary system (comprised of the gall bladder, cystic
duct, common duct, and extrahepatic ducts) were either derived
from earlier PDX1-expressing cells (Figure 1F) or from de novo
PDX1 expression (Offield et al., 1996). Although the extrahepato-
biliary system is derived from PDX1-expressing cells, our analysis
of Pdx1 null embryos (Pdx1tTA/tTA) demonstrates that Pdx1 is not
necessary for development of SOX17-expressing biliary primor-
dium or subsequent development of the gall bladder, collecting
duct, and common duct (Figure 1G), which is consistent with
previous reports (Jonsson et al., 1994; Offield et al., 1996). These
data indicate that the biliary primordium and ventral pancreas are
both derived from a PDX1+ ventral foregut progenitor.
Sox17 Is Necessary for Development of the Biliary
Primordium
To investigate the function of Sox17 in pancreatobiliary develop-
ment, we deleted Sox17 in the ventral foregut starting at E8.5
using two different Cre lines (Pdx1-cre and FoxA3cre; Lee et al.,
2005a; Wells et al., 2007) and two differentSox17 alleles (a condi-
tional Sox17Flox allele and a null Sox17GFP allele; Kim et al., 2007;
Figure S2). Deletion of Sox17 was efficient in e.9.5 embryos
(FoxA3cre;Sox17Fl/Fl-LOF) and resulted in an expansion of
PDX1 expression throughout the ventral gut, which is the
presumptive gall bladder region where Pdx1 is normally downre-
gulated (Figures 2A and 2B). At E10.5, control embryos had
a distinct PDX1+ ventral pancreas and SOX17+ biliary primor-
dium, whereas the biliary primordium was absent in FoxA3cre;
Sox17Fl/Fl embryos (Figures 2C and 2D). Similar phenotypes
were observed in E10 Pdx1-cre;Sox17Fl/GFP embryos (Figures
2E and 2F). The loss of the biliary primordium in E9.5 Sox17-
LOF embryos wasnot due to any quantitative change of cell prolif-
eration (phosphohistone H3 staining) or cell death (caspase-3
staining) (n = 4 different animals; Figure S4). These results demon-
strate thatSox17 is required for development of the biliary primor-
dium and suggest that biliary cells adopt a PDX1+ pancreatic fate.
In these experiments, Pdx1-cre;Sox17Fl/Fl embryos had a less
severe phenotype than Pdx1-cre;Sox17GFP/Fl because the latter
already lack one functional allele ofSox17 (Sox17GFP) (Figure S3).Developmental Cell 17, 62–74, July 21, 2009 ª2009 Elsevier Inc. 63
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Domains between the Liver and Pancreatobiliary
System
As described above, Sox17-LOF embryos had PDX1 expressed
throughout the ventral gut endoderm (Figures 2B and 2F), which
is not due to loss of presumptive biliary cells through cell death or
reduced proliferation (Figure S4). This suggests that Sox17 is
Figure 1. SOX17 and PDX1 Are Coex-
pressed in Ventral Foregut Progenitor Cells
(A) Sagittal section of an E8.5 embryo showing that
PDX1 (red) and SOX17 (blue) are coexpressed in
the ventral foregut in a domain adjacent to the
HHEX (green)-positive liver primordium. Only a
few cells at the boundary between the PDX1/
SOX17 and HHEX domains coexpress PDX1,
SOX17, and HHEX (arrows). Right panels show
individual channels. The cardiac mesoderm is indi-
cated with dashed lines. The boxed region in the
schematic on the right highlights the relative
region of the staining and the orientation of the
embryo (A, anterior; P, posterior).
(B) Transverse section of an E9.5 showing that
the SOX17/PDX1 coexpression domain has
begun to separate into a ventrally located SOX17-
high/PDX1-low domain a PDX1-high/SOX17-low
domain. SOX17 protein (blue) and PDX1 protein
(red) are shown in separate color channels.
(C) At E9.5 both the dorsal and ventral foregut are
lineage-labeled using Pdx1-cre and Rosa26-LacZ
(R26R) mice.
(D) At E10.5 the PDX1 and SOX17 expression
domains resolve into a PDX1-expressing (red)
ventral pancreas (vp) and a SOX17-expressing
(green) biliary primordium/gall bladder (pgb).
PDX1 is also expressed in the dorsal pancreas
(dp) and midgut (mg).
(E) The E10.5 biliary primordium/gall bladder
comes from a PDX1-expressing progenitor cell.
The gall bladder primordium is negative for the
PDX1 protein but is lineage-labeled by Pdx1-cre
in Rosa26-LacZ mice.
(F) Pdx1-cre lineage tracing shows that at E16.5
the duodenum (d), ventral pancreas (vp), dorsal
pancreas (dp), gall bladder (gb), collecting duct,
common duct, and cystic duct are all descendants
of a PDX1-positive precursor. Inset (top) shows
a section through the gall bladder lineage-labeled
with LacZ. Inset (bottom) shows the common duct
and cystic ducts lineage-labeled with LacZ.
(G) Pdx1 is not required for normal biliary develop-
ment. At E16.5, Pdx1 null mice (PdxttTa/tTa) lack
a pancreas, but have a gall bladder and cystic
duct. Scale bars in (A), (B), and (D) are 20 mm.
required to restrict Pdx1 expression to
the proper domain along the dorsal-
ventral axis. We next investigated if
Sox17 is also required for establishing or
maintaining boundaries between the pan-
creatobiliary and liver domains. In control
embryos between E9.0–9.5, there are
discrete boundaries between the liver
bud (PROX1+) and the pancreatobiliary
domain (PDX1+ and SOX17+). PDX1 expression is almost never
seen in the liver bud of control embryos. In contrast, we observed
ectopic PDX1-expressing cells throughout the liver bud of E9.5
FoxA3cre;Sox17Fl/Fl embryos (Figures 2G, 2H, 2G0, 2H0, and 2I),
and in Pdx1-cre;Sox17Fl/GFP and FoxA3cre;Sox17Fl/GFP embryos
(data not shown). Quantitation of the number of PDX1+ cells in
the PROX1+ liver bud showed that Sox17-LOF embryos had64 Developmental Cell 17, 62–74, July 21, 2009 ª2009 Elsevier Inc.
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ment of the Biliary Primordium and for
Establishing and/or Maintaining Organ
Boundaries between thePancreas and Liver
(A and B) PDX1 (red) and SOX17 (blue) expression
in the ventral foregut of (A) E9.5 control FoxA3cre;
Sox17Fl/+ embryos or (B) FoxA3cre;Sox17Fl/Fl
embryos, which show an almost complete loss
of SOX17 (blue) expression and a ventral expan-
sion of PDX1 expression. Dashed lines outline
the ventral region of the gut tube where the ventral
pancreas (red) and biliary system (blue) are devel-
oping.
(C and D) PDX1 (green) and SOX17 (red) expres-
sion in E10.5 control (C) and FoxA3cre;Sox17Fl/Fl
(D) embryos. FoxA3cre;Sox17Fl/Fl embryos entirely
lack a biliary/gall bladder primordium. PDX1 stain-
ing (green) marks the dorsal and ventral pancreas
in both control and FoxA3cre;Sox17Fl/Fl embryos.
(E and F) In E10.0 control embryos (E), the ventral
PDX1/SOX17 domains have begun to resolve into
a distinct PDX1-expressing ventral pancreas (red)
and a SOX17-expressing biliary primordium (blue).
In Pdx1-cre;Sox17Fl/GFP embryos (F) the SOX17-
expression domain is replaced by PDX1-positive
epithelium and there is no evidence of a biliary
bud. Dashed lines outline the ventral region of
the gut tube where the ventral pancreas (red) and
biliary system (blue) are developing.
(G and H) PDX1 (red), SOX17 (blue), and PROX1
(green) expression in E9.5 control (G) or Foxa3cre;
Sox17Fl/Fl (H) embryos. At E9.5 PDX1 (red)-positive
cells are almost never seen in the ventral most part
of the liver diverticulum (G and G0). However, in
FoxA3cre;Sox17Fl/Fl embryos (H and H0) there
were many PDX1-positive cells scattered through-
out the liver diverticulum.
(I) Quantitation of ectopic PDX1+ cells in the liver diverticulum (Sox17-LOF include FoxA3cre;Sox17Fl/Fl and FoxA3cre;Sox17Fl/GFP embryos). There were 10-fold
more PDX1+ cells in the Sox17-LOF liver bud than in controls (control 0.7 ± 0.7 cells/liver bud [n = 3] versus Sox17-LOF 7.8 ± 3 cells/liver bud [n = 5], p < 0.05).
Error bars denote standard error.
(J) Schematic of Sox17-LOF results. At E9.5, deletion of Sox17 results in loss of biliary cells and an expansion of PDX1+ cells into the liver bud. By E10.5 Sox17-
LOF embryos completely lacked the biliary primordium. The schematic only shows the ventral region of the gut and not the dorsal pancreas. Lines denote the
plane of section shown in (A–H).a 10-fold higher number of ectopic PDX1+ cells within the liver
bud (7.8 ± 3 cells per liver bud section, p < 0.05, n = 5) relative
to control embryos (0.7 ± 0.7, n = 3). This was confirmed by anal-
ysis of sagittal sections of Pdx1-cre;Sox17Fl/GFP embryos at
E9.0–E9.5 that clearly showed ectopic PDX1+ cells in the liver
bud (Figures S5A and S5B). When we analyzed embryos that
were totally null for Sox17 (Sox17GFP/GFP), the PDX1 domain
was almost completely contained within the PROX1 domain
(Figures S5C and S5D). These data suggest that Sox17 is
required for establishing and/or maintaining distinct domains
between the liver and the developing pancreatobiliary system
along the anterior-posterior axis (Figure 2J).
Embryos Lacking Sox17 Have Biliary Agenesis
and Ectopic Pancreatic Tissue in the Ducts
E10.5 Sox17-LOF embryos had agenesis of the biliary primor-
dium, and this manifested as a loss of the gall bladder and cystic
duct at E16.5 (Figures 3A and 3B). Moreover, 50% of the E16.5
FoxA3cre; Sox17Fl/Fl embryos had visible ectopic pancreatic
tissue in the common duct, consistent with the presence ofectopic PDX1 cells at E10 (Figures 3A0 and 3B0) (n = 4). Hematox-
ylin and Eosine (H&E) and antibody staining of sections through
the common duct showed pancreatic tissue budding from the
common duct in Sox17-LOF embryos (Figures 3C and 3D). We
confirmed that this was not due to a plane of section by dissect-
ing the common duct away from the pancreas and liver. Immu-
nohistochemical analysis of the dissected common duct of
E16.5 controls showed a single-layered epithelium that was
positive for the duct specific lectin, DBA, and for PDX1, which
are normally expressed in the duct at this stage (Figures 3C–
3C00 0). In contrast, the marker expression profile of Sox17-LOF
ducts was remarkably similar to that of the pancreas—branching
amylase-positive tissue and small islet-like clusters of insulin/
glucagon-positive cells budding off of the DBA positive duct
(Figures 3D–3D00 0) and reduced levels of PDX1. Control ducts
had rare insulin/glucagon-positive cells as previously reported
(Dutton et al., 2007) and never expressed amylase. The ectopic
endocrine clusters in Sox17-LOF ducts were often negative for
the duct markers HNF6 and DBA, suggesting that they had lost
a ductal phenotype (Figure 3 and data not shown). This suggestsDevelopmental Cell 17, 62–74, July 21, 2009 ª2009 Elsevier Inc. 65
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(A and B) As compared to control embryos at E16.5 (A), FoxA3cre;Sox17Fl/Fl embryos (B) completely lack a gall bladder (gb). However, the liver (L), intestine (i),
pancreas (p), and stomach (s) appear grossly normal. In (B) the arrow points to a blood vessel (bv) in between the lobes of the liver. (A0) and (B0) show a different
view of (A) and (B). In this view, the common duct is visible (dashed lines). The boxed area in the inset shows ectopic pancreatic tissue in the common duct.
(C and D) H&E stained section through the pancreas (P), duodenum (d), and common duct (arrowhead) of a Sox17Fl/Fl control embryo and a FoxA3cre;Sox17Fl/Fl
embryo at E16.5. The arrowhead points to the common duct, which has pancreatic tissue budding out of the duct in Sox17-LOF embryos (D). In both controls and
Sox17-LOF, the pancreas (P) and duodenum (d) appear normal. (C0–C000) Control and (D0–D000) FoxA3cre;Sox17Fl/Fl sections through the common duct stained with
the duct specific lectin, DBA (red), insulin plus glucagon (green), and amylase (blue) (C0 and D0); somatostatin (red), insulin (green), and the duct marker, HNF6
(blue) (C00 and D00); or PDX1 (red), glucagon (green), and HNF6 (blue) (C000 and D000). Sox17-LOF ducts have ectopic pancreatic tissue that expresses both exocrine
and endocrine markers.that removing Sox17 in the common duct is sufficient to induce
ectopic pancreas development. It is therefore not surprising
that deleting Sox17 has no obvious effect on normal pancreas
development (data not shown).
Sox17 Misexpression Suppresses Pancreas
Development
Our data suggest a model where SOX17 represses pancreatic
fate in the bilary primoridium, and that SOX17 must be downre-
gulated in the ventral pancreatic cells as they separate from the
biliary lineage. We tested this possibility by maintaining SOX17
in the pancreatic lineage using a Pdx1-driven tetracycline trans-
activator mouse (Pdx1tTa/+) and a tetracycline regulated Sox17
transgene (Pdx1tTa/+;tetO-Sox17 = Sox17 gain-of function
[GOF]; Holland et al., 2002; Park et al., 2006). In this system
the Sox17 transgene is ON in the absence of doxycyline, where
as administering Dox turns the Sox17 transgene OFF. In Sox17-
GOF embryos that were never fed doxycycline (ON), SOX17 was
ectopically expressed in PDX1-expressing cells starting at E9.5
(data not shown) and by E10.5 SOX17 was expressed
throughout the PDX1 domain. These embryos had a remnant
of a dorsal and ventral pancreatic bud, which were fused to
the gut tube (Figure 4A compared to control in Figure 1). Forma-
tion of the biliary epithelium was relatively normal in Sox17-GOF
embryos at E10.5, indicating that ectopic SOX17 can suppress66 Developmental Cell 17, 62–74, July 21, 2009 ª2009 Elsevier Inc.pancreas formation without affecting segregation of the biliary
lineage.
Since the dorsal and ventral pancreas do not bud properly
in Sox17-GOF embryos, we hypothesized that maintaining
SOX17 in the pancreatic domains suppresses pancreas devel-
opment. Consistent with this, expression of the pancreatic tran-
scription factor Nkx2.2 is dramatically reduced in Sox17-GOF
embryos relative to control embryos (Figures 4B and 4C).
NKX2.2 was only expressed in areas where SOX17 was not
ectopically expressed (Figure 4C, boxed region and inset). Other
pancreatic markers, such as PDX1 and PTF1a, were not affected
by ectopic SOX17 expression (Figures 4A, 4H, and 4I). These
data suggest that SOX17 inhibits pancreas development down-
stream of PDX1 and PTF1a and upstream of NKX2.2. It also
suggests that SOX17 does not directly downregulate Pdx1
during separation of the pancreatic and biliary lineages.
We examined expression of HNF6 and HHEX, which are also
expressed in this region of the gut. HHEX is normally restricted
to the ventral gut structures at E10.5, including the ventral
pancreas, and biliary and liver primordia (Bort et al., 2004; Hunter
et al., 2007), but is not normally expressed in the midgut or dorsal
pancreas. However, in Sox17-GOF embryos HHEX expression
was dorsally expanded into the gut and even expressed in the
presumptive dorsal pancreas (Figures 4F and 4G). The normal
expression of HNF6 throughout the biliary primordium, dorsal
Developmental Cell
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misexpression at E10.5 (Figures 4D and 4E). As expected, liver
bud development was not altered in Sox17-GOF embryos since
the Pdx1tTa is not active in the liver (data not shown). Taken
together these results suggest that SOX17 suppresses pancre-
atic fate and that downregulating SOX17 in the PDX1 domain
is crucial for normal pancreas development.
Figure 4. SOX17 Suppresses Pancreas
Development and Ventralizes the Gut
(A) Ectopic SOX17 expression in the PDX1 domain
using the Pdx1tTA tetracycline transactivator
system. In E10.5 Pdx1tTA;tetO-Sox17 embryos,
ectopic SOX17 expression ([A0], blue) is seen
throughout the PDX1 expression domain ([A],
red). The gall bladder primordium expresses
endogenous SOX17 (blue), but not Pdx1 ([A00],
arrowheads).
(B, D, and F) Control E10.5 embryos expressing
Nkx2.2 and Sox17 (B), HNF6 (D), Hhex and Pdx1
(F) protein.
(C, E, and G) Pdx1tTA;tetO-Sox17 embryos at
E10.5 expressing NKX2.2 and SOX17 (C), HNF6
(E), HHEX and PDX1 (G) protein. In Pdx1tTA;tetO-
Sox17 embryos, NKX2.2 expression in the dorsal
and ventral pancreatic buds is dramatically
decreased and HHEX expression is expanded
dorsally ([G], arrowheads). NKX2.2 is still ex-
pressed only in areas where tetO-Sox17 is not
activated ([C], inset). Insets in (F) and (G) show
PDX1 expression (red).
(H and I) The transcription factor PTF1A (green)
and SOX17 (blue) in control embryos (H) and in
Pdx1tTA;tetO-Sox17 embryos (I). PTF1A is nor-
mally expressed in the presumptive dorsal and
ventral pancreas, and but ectopic PTF1A-positive
cells are also seen in the middle part of the gut of
Sox17-GOF embryos, suggesting a patterning
defect.
(J) Schematic of control versus Sox17-GOF
embryos. In control embryos at E10.5, NKX2.2
(red) is restricted to the dorsal and ventral pancreas
whereas SOX17 (blue) is restricted to the gall
bladder primordium and HHEX expression (green)
is seen in the liver bud, gall bladder primordium,
and ventral pancreas. In Sox17-GOF embryos,
Sox17 expression is activated throughout the
PDX1 expression domain, which results in failure
of the dorsal and ventral pancreas to bud,
a decrease in NKX2.2 expression and a dorsal
expansion of HHEX into the gut and presumptive
dorsal pancreas.
SOX17 Misexpression Causes
Organ Dysgenesis throughout
the PDX1 Domain
SOX17 misexpression suppressed early
pancreatic developmentandmispatterned
the gut, but it was not clear what these
cells had become in response to SOX17
expression. Since SOX17 is required for
biliary specification, one possibility is that
SOX17 misexpression directed some of
these cells into a biliary and ductal fate. In
order to test this we analyzed the fate of SOX17-expressing cells
at E16.5. Compared to control embryos, Sox17-GOF embryos
had a large mass at the pyloric junction (Figures 5A–5D) and had
a dramatic decrease in the amount of pancreatic tissue (Figure 5B;
Figure S4). In lineage-traced embryos (Pdx1-tTa;tetO-cre;tetO-
Sox17;R26R) we found that the entire ectopic structure was
derived from SOX17-overexpressing cells (Figure S6).Developmental Cell 17, 62–74, July 21, 2009 ª2009 Elsevier Inc. 67
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many ectopic duct-like structures that expressed the duct
marker HNF6 (Figures 5E and 5F). The stomach epithelium and
mesenchyme in the GOF embryos both appeared hyperplasic
(Figure 5D). While some ectopic ductal tissue was negative for
Figure 5. SOX17 Expression Is Sufficient to
Induce Ectopic Ductal Tissue, Pancreas
Agenesis, and Gut Malformations at E16.5
(A and B) Stomach, duodenum, dorsal and ventral
pancreas at E16.5 in control Pdx1tTA (A) and
Pdx1tTA;tetO-Sox17 (B) embryos. SOX17-overex-
pressing embryos develop a large mass of tissue
at the border between the stomach and duo-
denum and have only a pancreatic remnant.
(C andD)H&Estained sectionsofcontrol (C)Pdx1tTA
and (D) Pdx1tTA;tetO-Sox17 embryos at E16.5
showing the stomach, pylorus, and duodenum.
(E and F) HNF4a protein (red) is in the duodenum
and HNF6 protein (green) is in the developing
cystic duct (inset) of Pdx1tTA control (E) embryos
at E16.5. In Pdx1tTA;tetO-Sox17 (F) embryos
HNF4a and HNF6 are coexpressed in the epithe-
lium of the ectopic mass and HNF6 is expressed
in ectopic duct-like structures that are found
throughout the mass of tissue.
(G and H) Villin expression is seen in the normal
duodenum of Pdx1tTA control (G) and Pdx1tTA;
tetO-Sox17 (H) embryos. However, the ectopic
mass of tissue in Pdx1tTA;tetO-Sox17 embryos
contains villin-positive intestinal epithelium and
villin-negative epithelium.
the gut epithelial marker HNF4a, other
regions were HNF6/HNF4a double-posi-
tive, suggesting that these cells had the
properties of both gut and ductal epithe-
lium (Figure 5F). The ectopic tissue mass
contained regions of duodenal-like villi
that were interspersed with a hyperplasic
ductal-like epithelium. The gut epithelial
marker villin (Braunstein et al., 2002;
Figure 5G) was absent from large regions
of the protuberance in Sox17-GOF
embryos (Figure 5H). These data suggest
that persistent SOX17 expression sup-
presses pancreatic development and is
sufficient to induce ectopic ductal tissue
in the stomach and duodenum. Since
there is no marker that can distinguish
one type of ductal epithelia from another,
it is impossible to determine if the ectopic
ductal tissue present in the Sox17-GOF
embryos is biliary.
The Role of Sox17 in Directing
a Biliary versus Pancreatic Cell
Fate Choice Is Temporally
Restricted to E8.5-E10.5
Since the tetO-Sox17 transgene was
constitutively misexpressed between
E8.5 and E16.5 of development, it was not clear when during
development SOX17 misexpression was causing these pheno-
types. To investigate this, we gave a pulse of SOX17 expression
for different lengths of time between E8.5 to E12.5 and then
analyzed the embryos at E16.5. We found that misexpression68 Developmental Cell 17, 62–74, July 21, 2009 ª2009 Elsevier Inc.
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maintained expression from E8.5-E16.5: loss of pancreatic
tissue and the formation of a tissue mass containing ectopic
ductal tissues and disorganized stomach and duodenal epithe-
lium (Figures 6A and 6D). In the converse experiment where
the Pdx1tTa/+; tetO-Sox17 transgene was induced after E12.5,
pancreatic development was grossly normal and no ectopic
mass was detected at the pyloric-duodenal junction (data not
shown). We based the timing of tetO-Sox17 on previous exper-
iments that demonstrated that the Pdx1 tet-transactivator initi-
ates transgene expression at E8.5 and is downregulated within
1 day of doxycycline treatment (Hale et al., 2005).
Sox17 Misexpression Is Sufficient to Induce a Ductal
Cell Fate in the Pancreas at the Expense of Other
Lineages
Given the appearance of ectopic ductal tissue in the duodenum
of the Sox17-GOF embryos, we hypothesized that SOX17 might
have the general property of promoting a ductal fate. To test this
we misexpressed SOX17 in the pancreas of animals starting
at E12.5, where it is normally not expressed (SOX17 ON in
Pdx1-cells at E12.5) and examined the pancreas at E16.5 and
at 6 weeks (Figures 6G–6J). At E16.5, the Sox17-GOF pancreas
was the same size as in control animals, however histological
analysis showed a dramatic increase in DBA-positive ductal cells
Figure 6. Use of the Tet-Regulatible System
Shows that Sox17 Has Distinct Temporal
Activities
(A–F) Sox17 misexpression between E8 and 10.5
causes organ dysgenesis in the PDX1 domain.
Following Pdx1tTA- mediated activation of the
tetO-Sox17 transgene at E8.5 we extinguished
transgene expression at E9.5 (D), E10.5 (E), and
E12.5 (F) by feeding the animals doxycycline
(DOX). Control Pdx1tTA embryos developed nor-
mally (A–C). All Pdx1tTA;tetO-Sox17 mice (D–F)
developed a mass and ectopic ducts, indicating
that maintaining SOX17 for only a short period of
time during development is sufficient to suppress
pancreas development and cause mispatterning
of the stomach and duodenum.
(D0 and D00) Adjacent sections of (D) were immuno-
stained for the molecular markers HNF6 (green),
PDX1 (blue), and HNF4a (red) (D0), or glucagon
(green), insulin (blue), and villin (red) (D00). A large
tissue mass developed in these embryos, and
HNF6, PDX1, and HNF4a was seen in ectopic
duct-like structures. Ectopic glucagon and insulin
expression was seen outside of the pancreas (P),
in between the stomach (S) and duodenum/mass
(D). The boxes in (D0 and D00) show a magnified
view of individual channels in the panels to the
right. Arrows and arrowheads point out ectopic
glucagon and insulin-positive cells, respectively.
(G and H) SOX17 misexpression in the pancreas
from E12.5 results in ectopic ductal tissue at
E16.5. E16.5 pancreas from Pdx1tTA control (G)
and Pdx1tTA;tetO-Sox17 embryos (H) where
tetO-Sox17 was induced at E12.5 (ectopic
SOX17 ON at E12.5). E16.5 control embryos
show typical cords of PDX1 (green)-positive cells
interspersed with DBA (red)-positive ducts and
surrounded by amylase (blue)-positive exocrine
pancreas (G). In Pdx1tTA;tetO-Sox17 embryos,
cells expressing high levels of PDX1 are absent
and there is a marked increase in DBA-positive
ducts and a reduction in exocrine pancreas tissue.
(I and J) SOX17 misexpression in the pancreas from
E12.5 results in ectopic ductal tissue in the adult
pancreas. H&E staining of adult pancreas from
Pdx1tTA controls (I) and Pdx1tTA;tetO-Sox17
embryos (J) where tetO-Sox17 was induced at
E12.5 (ectopic SOX17 ON at E12.5). Relative to
the control pancreas the Pdx1tTA;tetO-Sox17
pancreas has a dramatic expansion of ductal tissue
at the expense of endocrine and exocrine tissue.
The inset in (J) shows a higher magnification of
a region that contains numerous ductal structures.Developmental Cell 17, 62–74, July 21, 2009 ª2009 Elsevier Inc. 69
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nately to Segregate the Pancreatobiliary
Primordia
(A and B) Dorsal expansion of SOX17-expressing
cells in Hes1/ embryos at E9.5. SOX17 and
PDX1 protein in Hes1+/ (A) and Hes1/ (B)
embryos at E9.5. In Hes1+/ embryos SOX17
protein (gray) is restricted to the ventral-most
part of the foregut and PDX1 protein (red) is high-
est in the presumptive ventral pancreas. HES1
protein (green) is found throughout the ventral
foregut region and overlaps with both SOX17
and PDX1. In Hes1/ embryos (B) SOX17+ cells
are expanded dorsally (gray) into the dorsal
pancreas (inset, arrows point to ectopic SOX17
cells). See Figure S8 for separated color channels.
(C and D) The SOX17 and PDX1 expression
domains are disrupted in Hes1/ embryos at
E10.5. SOX17, HHEX, and PDX1 protein in
Hes1+/ (C) and Hes1/ (D) embryos at E10.5.
In control embryos (C) SOX17 (blue) and HHEX
(green) are expressed in the gall bladder primor-
dium and a PDX1+ ventral pancreas and gut
tube (red). In Hes1/ embryos (D) the biliary and
ventral pancreas are fused (dashed lines) and
mostly lack SOX17 (blue) and PDX1 (red) expres-
sion. The PDX1 expression in (D) is the gut tube.
Scale bars in (A–D) are 20 mm.
(E and F) HES1 protein is increased in Sox17 gain-
of-function embryos. In control E9.5 embryos (E),
high HES1 protein levels are associated with
PDX1/SOX17 coexpressing cells in the ventral
foregut. In Pdx1-tTa;tetO-Sox17 embryos, ectopic
SOX17 expression in the dorsal bud is associated
with elevated HES1 levels in PDX1 + cells ([E] and
[F], arrowheads).
(G and H) HES1 protein is decreased in Sox17 loss-of-function embryos. Compared to control E9.5 embryos, HES1 protein is only observed in a few cells of the
ventral gut of FoxA3cre;Sox17Fl/Fl loss-of-function embryos ([H], arrowheads). For separated HES1, PDX1, and SOX17 color channels, see Figure S9. PDX1
protein expression is largely unchanged. Scale bars in (A–D) are 20 mm.
(I) A model derived from Sox17 and Hes1 GOF and LOF data showing how SOX17 and HES1 might be part of a regulatory loop.relative to control animals (Figures 6G and 6H). This increase in
DBA-positive ductal tissue appeared to come at the expense
of endocrine cells, which were dramatically reduced in these
animals (data not shown). Furthermore, H&E staining showed
that the pancreas of 6-week-old Sox17-GOF animals had
a massive expansion of ductal tissue, whereas acinar tissue
was reduced and mature endocrine cells were nearly absent
(Figures 6I and 6J and data not shown). These results suggest
that SOX17 misexpression in the pancreas is sufficient to
promote a pancreatic ductal cell fate at the expense of the other
lineages.
Together with the loss-of-function data, we conclude that
SOX17 is required between E8.5 and E10.5 to properly segre-
gate the foregut progenitors into the biliary and pancreatic line-
ages, and that sustained SOX17 expression in the PDX1+ cells
in this period is sufficient to suppress pancreas and induce
ectopic biliary fate.
HES1 Regulates the Segregation of SOX17/PDX1
Lineages from Common Foregut Progenitors
Previous studies have implicated the Notch, FGF10, and
hedgehog signaling pathways in the development of the ventral
pancreas and biliary tree. We used existing mouse mutant lines70 Developmental Cell 17, 62–74, July 21, 2009 ª2009 Elsevier Inc.to determine if any of these pathways were involved in establish-
ing the SOX17/PDX1 pancreatic-biliary progenitor domain.
Embryos lacking either FGF10 (Fgf10 null) or the hedgehog
coreceptor smoothened (Pdx1-cre;smoothenedFl/Fl) formed a
normal SOX17+/PDX1+ progenitor domain that resolved into
biliary and pancreatic primordia that were indistinguishable
from control embryos at E10.5 (Figure S7). As previously
reported, Fgf10 null embryos at later stages had pancreatic
and biliary defects that occur after specification and segregation
of the ventral pancreas and gall bladder primordium (data not
shown).
In contrast, our analysis of embryos lacking Hairy Enhancer of
Split-1 (Hes1 /), a transcriptional effector of notch signaling,
demonstrated that Hes1 is required for formation of the ventral
pancreatic and biliary bud. In Hes1/ embryos at E9.5, the
SOX17 expression domain was expanded dorsally in a scattered
fashion, and we observe SOX17+ cells in the dorsal pancreas
(Figures 7A and 7B and inset); Figure 7 is presented with sepa-
rated channel colors in Figure S8. This suggests that HES1
acts to restrict SOX17+ cells to the ventral gut. At E10.5,
SOX17 and PDX1 expression was nearly absent in ventral endo-
derm of Hes1/ embryos, and the ventral pancreas and biliary
primordium did not develop into distinct structures (Figures 7C
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results in biliary agenesis, hypoplasia of the EHBD, and replace-
ment of the common duct with pancreatic tissue as previously
reported (Fukuda et al., 2006; Sumazaki et al., 2004). We have
not determined if HES1 is acting as a Notch effector in this
context, as it also can have Notch-independent effects.
In addition, our analysis of Sox17-LOF and Sox17-GOF
embryos suggests a functional connection between Sox17 and
Hes1 in controlling biliary development. First, the Sox17-LOF
phenotype is strikingly similar to Hes1/ animals, with gall
bladder agenesis and ectopic pancreatic tissue in the common
duct (Figures 2 and 3; Fukuda et al., 2006; Sumazaki et al.,
2004). Second, misexpression of SOX17 in PDX1-positive cells
in the dorsal and ventral pancreas coincides with an increase
in HES1 protein levels at E9.5 (Figures 7E and 7F, and
Figure S8) and E10.5 (Figure S9). Third, HES1 protein expression
is reduced in Sox17-LOF animals (Figures 7G and 7H) suggest-
ing that SOX17 appears to positively affect HES1 expression
but is not absolutely required for its expression. Lastly,
SOX17+/PDX1+ progenitor cells express higher levels of HES1
protein than SOX17/PDX1+ cells (Figure 7E and Figure S8E,
compare dorsal SOX17/PDX1+ versus ventral SOX17+/
PDX1+). Taken together our results suggest a model where
between E8.5 and 9.5, SOX17 and HES1 may be involved in a
regulatory feedback loop where high levels of SOX17 in PDX1-
positive cells act to promote Hes1 expression, which then in
turn progressively restricts SOX17-expressing, PDX1-negative
cells to the ventral gut (Figure 7I). Early cell segregation defects
in the Hes1 mutant embryo are associated with a reduction of
both SOX17- and PDX1-expressing cells at E10.5 and disruption
of organ development.
While our results clearly show that HES1 is required for proper
segregation of SOX17/PDX1 lineages from common foregut
progenitors, further studies are needed to elucidate the molec-
ular mechanism by which HES1 and SOX17 work to restrict
biliary progenitors to the ventral-most domain of the pancre-
atic/biliary bud.
DISCUSSION
A Sox17-Dependent Mechanism for Specifying Organ
Cell Fate and Establishing Boundaries Is Required
for Normal Pancreas, Biliary, and Liver Development
The liver, ventral pancreas, and biliary system are all derived
from several hundred endoderm cells found in the caudal region
of the ventral foregut. We present data to demonstrate a require-
ment for Sox17 in lineage choice between a pancreatic and
biliary cell fate. We propose a model (Figure S10) where SOX17
is broadly expressed in the presumptive foregut and is then
progressively downregulated in the different organ domains as
they are specified. For example, at E8.5 SOX17 is downregu-
lated in the presumptive HHEX+ domain as hepatic cells are
specified, then it is downregulated in the PDX1+ cells as ventral
pancreatic cells are specified. Finally, SOX17 expression is
maintained in a subset of biliary progenitors that give rise to
the gall bladder, cystic duct, common duct, and extrahepatic
bile ducts. Our data further suggest that Sox17 is required either
to establish or maintain distinct boundaries between the liver,
biliary, and pancreatic domain, since the loss of Sox17 resultsin ectopic PDX1 cells in the liver bud and biliary system. Further-
more, we have shown that the Sox17-dependent segregation of
pancreatic and biliary domains requires Hes1 (discussed below
and Figure S10). The factors that regulate the dynamic expres-
sion of Sox17 during foregut organogenesis still need to be
investigated.
Feedback between Sox17 and Hes1 During Biliary
and Pancreas Development
The Sox17 loss-of-function phenotype is strikingly similar to
Hes1/ animals, with gall bladder agenesis and ectopic pancre-
atic tissue in the common duct (Fukuda et al., 2006; Sumazaki
et al., 2004), suggesting that these two molecules act in the
same pathway. While Sox17 is not required for Hes1 expression,
our data indicate that SOX17 is able to regulate HES1 levels in
PDX1-expressing endoderm; HES1 protein is reduced in Sox17-
LOF animals and is elevated in PDX1+ cells that overexpress
SOX17 in the dorsal pancreas. Importantly, we observe higher
HES1 protein levels in the normal context of ventral cells that
coexpress PDX1 and SOX17, suggesting that progenitors are
defined as PDX1+/SOX17+/HES1high.
Interestingly, our data suggest that a negative feedback loop
exists between Hes1 and Sox17 since SOX17 cells expand
dorsally in Hes1/ embryos and SOX17+ cells are even found
in the dorsal pancreas. The absolute levels of SOX17 do not
change, suggesting that HES1 does not directly repress Sox17
expression; rather, HES1 restricts SOX17 cells to the ventral
part of the bud in an indirect manner. While more work is needed
to work out the exact details of how SOX17 and HES1 cooperate
to regulate lineage segregation, it is interesting to speculate
that PDX1 and SOX17 may be cooperating between E8.5 and
E9.5 to drive high HES1 levels, and that HES1 feeds back to limit
SOX17-expressing cells to the ventral gut (Figure S10). Our data
show that failure to ventrally restrict SOX17+ cells in Hes1/
embryos at E9.5 corresponds with loss of the biliary primordium
at E10.5. It is possible that some SOX17 cells at E9.5 are con-
verted to a pancreatic fate, consistent with the formation of
ectopic pancreatic tissue in Hes1/ embryos (Fukuda et al.,
2006; Sumazaki et al., 2004). Alternatively, early mislocalization
of SOX17+ cells might trigger their apoptosis, resulting in loss
of biliary structures by E10.5. This possibility remains to be
determined.
Our data explain why mutations in either Sox17 or Hes1 cause
similar phenotypes, and suggest that the reported phenotypes in
Hes1/ embryos are due in part to Sox17-dependent defects
and vice versa. Since SOX17 cells are not properly localized
Hes1/ embryos, and HES1 expression is reduced in Sox17-
LOF embryos, mutations in either would feed back and cause
failure in pancreas and biliary lineages to properly segregate,
loss of biliary tissue, and derepression of propancreatic factors.
Ectopic pancreas formation in Hes1/ embryos was attributed
to suppressing pancreatic transcription factors Ptf1a/p48 and
Ngn3 in ductal epithelia that already expressed endogenous
Pdx1 (Esni et al., 2004; Fukuda et al., 2006; Ghosh and Leach,
2006; Jensen et al., 2000; Sumazaki et al., 2004). It is not clear
if ectopic pancreatic tissue inSox17-LOF embryos is due to early
missegregation of biliary and pancreatic lineages or a reduction
in HES1 protein expression in the duct at later stages. Pancreatic
markers have been observed at low levels in the biliary systemDevelopmental Cell 17, 62–74, July 21, 2009 ª2009 Elsevier Inc. 71
Developmental Cell
Ventral Pancreas and Biliary System Development(Dutton et al., 2007), suggesting that this epithelium has latent
pancreatic potential that could be enhanced by removal of biliary
determinants like Sox17 or Hes1.
Sox17 Is Upstream in a Cascade of Transcription
Factors that Regulates Biliary Tree Development
The transcription factors HHEX, HNF6 (Onecut One), HNF1, and
HNF4 play roles in different aspects of biliary tree development
(Clotman et al., 2002; Hunter et al., 2007; Matthews et al.,
2004). Since our studies demonstrate that SOX17 is also
involved in early biliary development, it is possible that SOX17,
HHEX, and HNF6 form a transcriptional network that regulates
development of the biliary system. Consistent with this, misex-
pression of SOX17 throughout the dorsal PDX1 domain is suffi-
cient to induce ectopic expression of HHEX in the duodenum
and dorsal pancreas at E10.5. Moreover, SOX17 misexpression
is sufficient to induce the biliary/ductal molecular program result-
ing in HNF6 expression in ectopic ductal structures throughout
the PDX1 expression domain. These data suggest that SOX17
might act a master regulator of the biliary/ductal lineage
upstream of HHEX and is sufficient for diverting other cell types
into the biliary lineage. We have also shown that SOX17 over-
expression in the pancreas at E12.5, when it is not normally
expressed, is sufficient to promote a ductal fate, apparently at
the expense of endocrine cells. This supports the idea that
SOX17 acts at the top of a hierarchy and can activate a transcrip-
tional program resulting in a ductal fate.
An Alternative Model for Biliary Development
Our lineage tracing and gene expression data indicate that the
biliary system shares a common origin with ventral pancreas
and not the liver as previously thought (Figure S10; Clotman
et al., 2002; Hunter et al., 2007; Shiojiri, 1997). The fact that
Sox17- and Hes1-LOF affected the biliary and pancreatic line-
ages also supports this conclusion. Congenital defects have
been reported in humans that have linked anomalies in both
the pancreas and biliary system. It is likely that a common
progenitor for liver, biliary system, and pancreas exists at earlier
stages of development, when the anterior definitive endoderm is
forming the foregut, and that the first of these lineages to sepa-
rate is the liver. This possibility is supported by studies in Zebra-
fish, where single lineage-traced cells gave rise to committed
liver cells and PDX1-positive cells. Those PDX1-positive cells,
our data would suggest, are the pancreatobiliary progenitors.
These data describe a SOX17-based model for extrahepatic
biliary development from a PDX1 progenitor. It is important to
point out that the IHBDs were not lineage-labeled using Pdx1-
cre and were not affected in Sox17-LOF or Sox17-GOF studies
(data not shown). Therefore, development of the entire biliary
tree might be dependent on cells derived from different popula-
tions of progenitor cells. The EHBDs, common duct, cystic duct,
and gall bladder are derived from a PDX1+ progenitor cell,
whereas the IHBDs are derived from a hepatic progenitor cell
(Figure S10). This model could provide insight into the causes
of human congenital abnormalities affecting both pancreas and
biliary tree. Moreover, a better understanding of how endoderm
organ lineages are initially segregated will inform efforts at
directed differentiation of human ES cells into endoderm deriva-
tives (Spence and Wells, 2007).72 Developmental Cell 17, 62–74, July 21, 2009 ª2009 Elsevier Inc.EXPERIMENTAL PROCEDURES
Immunohistochemistry
Tissues were either fixed overnight and embedded in paraffin, or fixed for 1 hr,
equilibrated in 30% sucrose/13 PBS, and frozen in OCT. Sections were cut
6–10 mm thick. Paraffin sections were deparaffinized, dehydrated, and we per-
formed antigen retrieval by steaming slides in sodium citrate buffer for 30 min.
Sections were blocked in the appropriate serum (5% serum in 13 PBS + 0.5%
triton-X) for 30 min. Primary antibodies were diluted in blocking buffer and
incubated on tissue sections overnight at 4C. Slides were washed and incu-
bated in secondary antibody in blocking buffer for 2 hr at room temperature.
For a list of antibodies used and dilutions, see the Supplemental Experimental
Procedures. Slides were washed and mounted using Fluormount-G.
LacZ Staining and Histology Analysis
b-galactosidase activity was detected in fixed whole tissue using the Histo-
mark X-gal substrate system (Kireguard and Perry Laboratories, MD). For
hematoxylin and eosin staining, 6 mm paraffin sections were dewaxed in
xylene, rehydrated, and stained.
Mice
All mice used in these studies were housed at the Cincinnati Children’s
Hospital Research Foundation mouse facility, and were maintained according
to institutional protocols. Pdx1-cre, Pdx1-tTa, FoxA3cre, Sox17-GFP, FGF10,
SmoothenedFl and Hes1 mice have all been previously described (Bellusci
et al., 1997; Holland et al., 2002; Ishibashi et al., 1995; Kim et al., 2007; Lee
et al., 2005b; Wells et al., 2007; Zhang et al., 2001). The generation of the
Sox17Fl mice is described in the Supplemental Experimental Procedures.
SUPPLEMENTAL DATA
Supplemental Data include ten figures and Supplemental Experimental
Procedures and can be found at http://www.cell.com/developmental-cell/
supplemental/S1534-5807(09)00214-7/.
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